InformationGNE-9605 GNE-9605 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with K i and IC50 of 2 nM and 19 nM, respectively.TargetsLRRK2 ; LRRK2 2 nM(Ki); 19 nMIn vitroGNE-9605 is highly potent against LRRK2 in both biochemical (Ki = 2.0 nM) and cellular (IC50 = 19 nM) assays. In vitro human MDR1 permeability data, GNE-9605 exhibits excellent brain penetration in higher species.In vivoIn vivo rat PK studies with GNE-9605 (1 mg/kg, p.o.) demonstrates a total plasma clearance of 26 mL/min/kg with excellent oral bioavailability (90%). In BAC transgenic mice expressing human LRRK2 protein with the G2019S Parkinson’s disease mutation, GNE-9605 (10 and 50 mg/kg, i.p.) inhibits in vivo LRRK2 Ser1292 autophosphorylation.
Specifications and Purity: ≥98%
Molecular Formula: C17H20ClF4N7O
Molecular Weight: 449.83
PubChem CID: 76328936
Isomeric SMILES: CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4)Cl
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/G413750-SCI_80ae1870f3d334312f291928de72b9e9.pdf
- UPC:
- 12141605
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- G413750-50mg
- CAS:
- 1536200-31-3
- Product Size:
- 50mg
- Hazard Statement Codes:
- H302
- Precautionary Statement Codes:
- P305+P351+P338:P280
akash.verma@cenmed.com
(732) 447-1115





